Apoptosis Assays Market Research Report: By Product (Kits, Instruments), by Detection Technology (Flow Cytometry, Microscopy), by Application (Drug Discovery and Development), and by End User (Pharmaceutical and Biological, Hospital) - Forecast till 2030

Apoptosis Assays Market Overview The apoptosis assays market is expected to grow significantly over the forecast period. The market held a value of USD 2.99 billion in 2030 and is projected to register a CAGR of 9.80% over the forecast period 2022-2030. In multicellular organisms, apoptosis is a type of planned cell death. The goal of an apoptosis assay is to determine whether or not a cell is dying. It detects and measures caspase activation, phosphatidylserine (PS) cell surface exposure, and DNA fragmentation as part of programmed cell death. Factors such as rising R&D costs, rising cell-based research, and rising cancer research funding are likely to move the market forward. Over the projection period, however, the high expenditure required for research activities is likely to stifle market expansion. The increased incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others are driving the growth of the apoptosis assay market. The rise in the number of people suffering from chronic and autoimmune disorders is driving market expansion. A few more aspects are driving the apoptosis assay market forward, one of which is ongoing research into apoptosis-modulating medications, which is predicted to drive the global apoptosis assay market forward. However, the rising demand for high-content diagnostics and clinical research, particularly for cancer, is boosting market growth throughout the anticipated period. Infectious and chronic diseases such as autoimmune diseases, cancer, and others are on the rise, increasing market growth. Because of well-established companies and rising R&D costs, the Americas are expected to dominate the worldwide apoptosis assays market.

Segmentation:

The apoptosis assays market has been segmented into product, detection technology, application, and end user.

Based on product, the apoptosis assays market is segmented into kits, reagents, instruments, and others. The kits segment accounted for the largest share segment of the market in 2017.

Based on detection technology, the apoptosis assays market is segmented into flow cytometry, fluorescence microscopy, western blot assessment, gel electrophoresis, and others.

Based on application, the apoptosis assays market is segmented into drug discovery and development, stem cell research, and others.

Based on end user, the apoptosis assays market is segmented into pharmaceutical and biological companies, research institutes, and others.

The apoptosis assays market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The apoptosis assays market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European apoptosis assays market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The apoptosis assays market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The apoptosis assays market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global apoptosis assays market owing to well-established players and increasing R&D expenses.

Europe is expected to hold the second largest position in the global apoptosis assays market. The market growth in this region is attributed to the growth in the pharmaceutical and biotech industry.

The apoptosis assays market in the Asia-Pacific region consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region. The Middle East and Africa has the least share of the market.Global Apoptosis Assays Market Share (%), by Region, 2017

Source: Annual Reports and Sec filings

Key players:

Abcom plc, Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), and Promega Corporation (US) are some of the key players in the apoptosis assays market.Recent Development

Intended Audience

• Apoptosis assays products manufacturers and vendors


• Pharmaceutical and biotech companies


• Contract research organizations


• Various research and consulting firms

Apoptosis Assays Market, by Product

• Kits


• Reagents


• Instruments


• Others

Apoptosis Assays Market, by Detection Technology

• Flow Cytometry


• Fluorescence Microscopy


• Western Blot Assessment


• Gel Electrophoresis


• Others

Apoptosis Assays Market, by Application

• Drug Discovery and Development


• Stem Cell Research


• Others

Apoptosis Assays Market, by End User

• Pharmaceutical and Biological Companies


• Research Institutes


• Others

Apoptosis assays Market, by Region

• 
  Americas
  
  
  
  • 
    North America
    
    
    
    • US
    
    
    • Canada
    
    
    
    
  
  
  • South America
  
  
  
  


• 
  Europe
  
  
  
  • 
    Western Europe
    
    
    
    • Germany
    
    
    • France
    
    
    • Italy
    
    
    • Spain
    
    
    • UK
    
    
    • Rest of Western Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  


• 
  Asia-Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
   Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa